Jump to content

amokk20us

Member
  • Posts

    676
  • Joined

  • Last visited

amokk20us's Achievements

Newbie

Newbie (1/14)

0

Reputation

  1. kinda weird the SP is on the down? PHARMAXIS’ FIRST PRODUCT, ARIDOL, APPROVED BY THERAPEUTIC GOODS ADMINISTRATION Specialist pharmaceutical company Pharmaxis Ltd (ASX:PXS, NASDAQ:PXSL) announced today that the Therapeutic Goods Administration (TGA) has approved its first product, Aridol™, for commercial sale in Australia. This represents a rare example of an Australian human therapeutic product developed in Australia from concept to commercialisation. Aridol is designed to identify patients with active asthma and provide information on the severity of the disease and the effectiveness of their current treatment. More than 2 million people in Australia and 52 million people worldwide live with the disease. Currently, there is no registered, objective test to measure inflammation and hyper-responsiveness in the airways – the symptoms of active asthma. Aridol fills this gap. Alan Robertson, Pharmaxis chief executive officer said: “This is a significant milestone for Pharmaxis, and demonstrates the capability and potential of the company. The assistance and advice of the TGA has been very helpful as we have moved Aridol through its development and evaluation to final commercialisation. We have full commercial rights to Aridol, and we can now set about building a profitable Aridol business. “Aridol offers better health outcomes for people with asthma and the product launch preparations are under way. Our marketing program will initially make Aridol available to respiratory specialists and laboratories. Aridol was conceived over ten years ago, and today’s decision represents the culmination of significant effort by many people over many years.†Pharmaxis will market Aridol directly in Australia, and is negotiating European marketing agreements with specialised companies that are committed to improving standards in respiratory care, two of which are already in place.
  2. In reply to: PadMunter on Wednesday 22/03/06 03:00pm does anyone see an order at $2.41 ?
  3. $2.40 is a good price, I've just put in a small order. http://www.sharescene.com/html/emoticons/biggrin.gif
  4. I'd like to buy some more of PXS, but I think the market is pushing this too much. Im suscpeting some profit taking soon. But who knows she might keep running, too much volatility at this stage. Pity I can't write calls for PXS http://www.sharescene.com/html/emoticons/wink.gif
  5. In reply to: romaioi on Monday 20/03/06 02:50pm Hi Romaioi, Yes good price at closing, but I would have liked a bit more volume going through. In anycase, the Previous ANN should further strengthen Pharmaxis's managment. I hope however Dr Brett Charlton does not resent stepping down as director, and it was a voluntary move. We need another close tommrow above $2.20 with good volume, then we might see something special http://www.sharescene.com/html/emoticons/smile.gif http://www.sharescene.com/html/emoticons/graduated.gif
  6. MAJORITY OF PHARMAXIS BOARD NOW INDEPENDENT Specialist pharmaceutical company Pharmaxis Ltd (ASX:PXS, NASDAQ:PXSL) announced that its board is now composed of a majority of independent directors after Dr Brett Charlton advised today he was stepping down as a director. Dr Charlton will remain a member of the Company’s senior management team with responsibility for clinical trials and for new product approvals. In making the announcement Alan Robertson, Pharmaxis chief executive officer noted that the ASX Principles of Good Corporate Governance recommended a majority of independent directors. The appointment of Dr Peter Farrell to the Board last week cleared the way for Dr Charlton to step down. “Dr Charlton is a key member of the Pharmaxis management team and will continue to be involved with the board together with other members of our senior management.†he said. “Together with Dr Bill Cowden, Dr Charlton was a founding scientist of the Company and his contribution to the early development of Pharmaxis at all levels has been pivotal.â€ÂÂÂÂÂ
  7. Hi Romaioi, Thanks for posting the charts, its a shame the MACD bands haven't widen. the SP on close today will be very important, and should indicate whether this run will conitune or not. Again, fundementals for PXS are still very good, Charts help to create entry and exit stradegies. Have fun kids http://www.sharescene.com/html/emoticons/graduated.gif
  8. Whales are good. http://www.sharescene.com/html/emoticons/cool.gif
  9. That was weird mate... Westpac was showing PXS in pre-open at 3PM.... just before that huge trade
  10. why was PXS in pre-open?
  11. what the hell just happened?
  12. the question is, will it last till monday? Anyone care to take a stab at the Opening SP on Monday?
  13. sell order at $2.090 for 69,200 ... someone playing silly buggers
  14. I love this company's financial possiblities as well as its medical possiblities. Mix this values togather and let people with good principles and values lead the coporation, is worth investing in. Does anyone feel uncomforatble investing in companies such as timbercorp or metal storm? Anway, PXS looking on track.
  15. Yer I like predicted, The 2 year Weekly PAR SAR was hit last friday. http://www.sharescene.com/html/emoticons/graduated.gif
×
×
  • Create New...